Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Rogatti

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Angiology|March 24, 1999
Randomized reliability study evaluating constant-load and graded-exercise treadmill test for intermittent claudicationM Cachovan, W Rogatti, F Woltering, et al.
VASA. Supplementum|January 1, 1991
[Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities]T Weiss, J Griesshaber, W Rogatti, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 21, 1997
Treadmill testing for evaluation of claudication: comparison of constant-load and graded-exercise testsM Cachovan, W Rogatti, A Creutzig, et al.
Wiener Klinische Wochenschrift|July 15, 1988
[Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease]P Fitscha, T Simmet, B A Peskar, et al.
Prostaglandins|March 1, 1991
Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive diseaseB A Peskar, W H Hesse, W Rogatti, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 15, 1995
[Quality of life in peripheral arterial occlusive disease. Multicenter study of quality of life characteristics with a newly developed disease-specific questionnaire]H Heidrich, M Bullinger, M Cachovan, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
[Development of an illness-specific instrument for assessment of quality of life in patients with arterial occlusive disease (Peripheral Arterial Occlusive Disease 86 Questionnaire)]M Bullinger, M Cachovan, A Creutzig, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudicationA Creutzig, M Bullinger, M Cachovan, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|December 26, 2003
[DRG-based cost analysis of inpatient conservative treatment of stage III/IV peripheral arterial occlusive disease]H Heidrich, W Rogatti, E Altmann, et al.
Journal of Vascular Surgery|March 1, 1997
Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trialC Diehm, K Balzer, H Bisler, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Angiology|March 24, 1999
Randomized reliability study evaluating constant-load and graded-exercise treadmill test for intermittent claudicationM Cachovan, W Rogatti, F Woltering, et al.
VASA. Supplementum|January 1, 1991
[Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities]T Weiss, J Griesshaber, W Rogatti, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 21, 1997
Treadmill testing for evaluation of claudication: comparison of constant-load and graded-exercise testsM Cachovan, W Rogatti, A Creutzig, et al.
Wiener Klinische Wochenschrift|July 15, 1988
[Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease]P Fitscha, T Simmet, B A Peskar, et al.
Prostaglandins|March 1, 1991
Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive diseaseB A Peskar, W H Hesse, W Rogatti, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 15, 1995
[Quality of life in peripheral arterial occlusive disease. Multicenter study of quality of life characteristics with a newly developed disease-specific questionnaire]H Heidrich, M Bullinger, M Cachovan, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
[Development of an illness-specific instrument for assessment of quality of life in patients with arterial occlusive disease (Peripheral Arterial Occlusive Disease 86 Questionnaire)]M Bullinger, M Cachovan, A Creutzig, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudicationA Creutzig, M Bullinger, M Cachovan, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|December 26, 2003
[DRG-based cost analysis of inpatient conservative treatment of stage III/IV peripheral arterial occlusive disease]H Heidrich, W Rogatti, E Altmann, et al.
Journal of Vascular Surgery|March 1, 1997
Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trialC Diehm, K Balzer, H Bisler, et al.
Pageof 4